Shares of German drug discovery company Evotec leapt 20% to 10.33 euros this morning on the revelation that the USA’s ...

Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.

President-elect Donald Trump's selection of vaccine skeptic Robert F. Kennedy Jr. as health secretary weighed on global pharmaceutical stocks Friday. In Europe, shares in Bavarian Nordic fell more ...

The latest GDP figures come as a blow to Rachel Reeves, the chancellor, who said she was not "satisfied with the numbers".

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

The main UK stock indexes were subdued on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, ...

Sudarshan Pharma Industries has proposed a stock split, reducing the face value of each share from Rs 10 to Rs 1, with each ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in ...

It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...

Mankind Pharma announced the pledge of nearly 40 per cent of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited, ...

Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug ...